This webinar will help the attendee gain an understanding of the requirements of current USP <85> Bacterial Endotoxin Test (BET) European Pharmacopoeia (Chapter 2.6.14) and the Japanese Pharmacopoeia (General Tests, No. 4.01), the different testing methodologies and the criticality of the BET test result to the release of cGMP manufactured products.